TUCSON, Ariz., Feb. 04, 2016 -- Medication therapy management (MTM) technology developed by SinfoniaRx has expanded to support the growing Hispanic population that has reached nearly 57 million in the US. To help improve the treatment of chronic conditions in Hispanic populations, SinfoniaRx has launched a new call center located in the Phoenix area. “Prescriptions with a goal - partners in your health” or “Recetas con metas - compañeros en su salud" is SinfoniaRx’s clinical program focused on the Spanish speaking patient. SinfoniaRx’s Spanish speaking MTM providers are internationally recognized and experts in complex and chronic disease management.
In 2015, over 4,000 Comprehensive Medication Reviews (CMRs) were completed by SinfoniaRx’s Spanish MTM providers. In 2016, these numbers are anticipated to grow. According to the Centers for Disease Control (CDC), Hispanics have a higher incidence of diabetes and liver disease leading to a need for personalized MTM services.
SinfoniaRx’s technology is currently used by pharmacists at the University of Arizona and The Ohio State University to monitor prescription use for approximately 300 health plans representing 6 million patients nationally.
About SinfoníaRx:
SinfoníaRx is an innovative health care company whose mission is to provide the highest quality healthcare solutions for health plans, patients, and caregivers. We improve the health and wellness of patients with complex and chronic illnesses through the use of innovative healthcare technology and the most experienced medication therapy management providers in the nation.
Our proprietary software RxCompanion™ is a highly customizable and scalable platform designed to identify and resolve medication and other health related problems. Through a patient-centric population management approach, potential problems are triaged based on urgency and complexity, then resolved through telephonic, face-to-face, or video-based consultations.
In 2015, SinfoníaRx staff of approximately 400 pharmacists, pharmacy interns and pharmacy technicians working in our 3 contracted clinical call-centers located in Tucson and Phoenix, Arizona and Columbus, Ohio completed over 185,500 comprehensive medication reviews and made 895,164 recommendations to physicians to improve medication treatment. To date, our program has resolved more than 1,000,000 drug therapy problems resulting in more than $570 million in overall healthcare savings.
www.sinfoniarx.com
About Sinfonía HealthCare:
Sinfonía HealthCare was launched in January 2013 by pioneering healthcare executives Fletcher McCusker and Michael Deitch, the CEO, CFO team and founders of Providence Service Corporation (Nasdaq:PRSC). Sinfonía has created an innovative approach to community based medical care by establishing a full continuum of health services including: hospice, home health, companion care, primary care, wellness, and medication therapy management. Sinfonía also launched a behavioral health division designed to integrate mental health, pharmacy and primary care in Arizona, Florida, Louisiana, Maine, New Hampshire and Virginia. Sinfonía HealthCare is headquartered in Tucson, Arizona. www.sinfoniahealth.com
Contact: Sandy Mellor Director of Community Relations Sinfonía HealthCare Corp. 520-545-1102 [email protected]


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Italy Fines Apple €98.6 Million Over App Store Dominance
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
FDA Approves Mitapivat for Anemia in Thalassemia Patients 



